Cargando…

Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study

Antipsychotic polypharmacy (APP) in patients with schizophrenia spectrum disorders (SSDs) is usually not recommended, though it is very common in clinical practice. Both APP and SSDs have been linked to worse health outcomes and decreased levels of physical activity, which in turn is an important ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliva, Vincenzo, Fanelli, Giuseppe, Zamparini, Manuel, Zarbo, Cristina, Rocchetti, Matteo, Casiraghi, Letizia, Starace, Fabrizio, Martinelli, Alessandra, Serretti, Alessandro, de Girolamo, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722380/ https://www.ncbi.nlm.nih.gov/pubmed/36165505 http://dx.doi.org/10.1097/YIC.0000000000000433

Ejemplares similares

Comparing Adherence to the Experience Sampling Method Among Patients With Schizophrenia Spectrum Disorder and Unaffected Individuals: Observational Study From the Multicentric DiAPAson Project
por: Zarbo, Cristina, et al.
Publicado: (2023)

Quality of residential facilities in Italy: satisfaction and quality of life of residents with schizophrenia spectrum disorders
por: Martinelli, Alessandra, et al.
Publicado: (2022)

Needs for care of residents with schizophrenia spectrum disorders and association with daily activities and mood monitored with experience sampling method: the DIAPASON study
por: Martinelli, Alessandra, et al.
Publicado: (2023)

Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study
por: D’Anna, Giulio, et al.
Publicado: (2023)

DAily time use, Physical Activity, quality of care and interpersonal relationships in patients with Schizophrenia spectrum disorders (DiAPASon): an Italian multicentre study
por: de Girolamo, Giovanni, et al.
Publicado: (2020)

Machine-Learning for Prescription Patterns: Random Forest in the Prediction of Dose and Number of Antipsychotics Prescribed to People with Schizophrenia
por: Marchi, Mattia, et al.
Publicado: (2022)

Openness buffers the impact of Belief in Conspiracy Theories on COVID-19 vaccine hesitancy: Evidence from a large, representative Italian sample
por: Li, Tania Y., et al.
Publicado: (2023)

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China
por: Si, Tian-Mei, et al.
Publicado: (2011)

Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
por: Gamón, Verónica, et al.
Publicado: (2021)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022)

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
por: Apiquian, Rogelio, et al.
Publicado: (2004)

COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination
por: Zarbo, Cristina, et al.
Publicado: (2022)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy
por: Kim, Hee-Yun, et al.
Publicado: (2014)

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM
por: Brand, Bodyl A., et al.
Publicado: (2023)

A Study of an Antipsychotic Prescription Pattern of Patients with Schizophrenia in a Developing Country
por: Ramadas, Smitha, et al.
Publicado: (2010)

Conspiracy mentality and health-related behaviour during the COVID-19 pandemic: a multiwave survey in Italy
por: Candini, V., et al.
Publicado: (2023)

Older People Living in Long-Term Care Facilities and Mortality Rates During the COVID-19 Pandemic in Italy: Preliminary Epidemiological Data and Lessons to Learn
por: de Girolamo, Giovanni, et al.
Publicado: (2020)

Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia
por: Viala, Annie, et al.
Publicado: (2012)

Correlates of high-dose antipsychotic prescription amongst outpatients with Schizophrenia in a Nigerian Hospital
por: Anozie, Ihechiluru G., et al.
Publicado: (2022)

Psychological well-being during the COVID-19 pandemic in Italy assessed in a four-waves survey
por: de Girolamo, Giovanni, et al.
Publicado: (2022)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

Patterns of prescription of antipsychotics in Qatar
por: Ouanes, Sami, et al.
Publicado: (2020)

Does mental health staffing level affect antipsychotic prescribing? Analysis of Italian national statistics
por: Starace, Fabrizio, et al.
Publicado: (2018)

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis
por: Takekita, Yoshiteru, et al.
Publicado: (2015)

F35. PRESCRIPTION PATTERN OF ANTIPSYCHOTICS FOR CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA IN KOREA BASED ON NATIONWIDE DATA
por: Park, Kee Jeong, et al.
Publicado: (2018)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
por: Laszlovszky, István, et al.
Publicado: (2021)

Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)

Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors
por: Mandelli, Laura, et al.
Publicado: (2016)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona
por: Gaviria, Ana M., et al.
Publicado: (2015)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Peripheral Amino Acid Levels in Schizophrenia and Antipsychotic Treatment
por: De Luca, Vincenzo, et al.
Publicado: (2008)

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study
por: Park, Yong Chon, et al.
Publicado: (2018)

Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
por: Takahashi, Tatsuichiro, et al.
Publicado: (2020)

A commentary on “Antipsychotic-induced Parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders”
por: Salem, Amir, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rjm6pd0o11fnl4f795sfto42lh